MedTrace Logo

Multimodality Imaging Assessment of the Severity of Mitral Regurgitation

NCT06266858 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-02-20

No results posted yet for this study

Summary

To investigate to assess the severity of mitral regurgitation by multimodality imaging.

Conditions

  • Mitral Regurgitation

Interventions

OTHER

rehydration

The fasting patients in anaesthetised receive saline rehydration to maintain central venous pressure of 6-8 cmH2O when undergoing UCG.

DIAGNOSTIC_TEST

UCG

UCG is the most common imaging modality to assess the mitral regurgitation in clinical and also is the primary modality recommended by guidelines. At the beginning of the study, the fasting patients receive UCG in the different situation such as pre-anaesthetic, post-anaesthetic and post-rehydration.

DIAGNOSTIC_TEST

CMR

CMR may be more accurate than UCG in assessing MR severity. In another time, the patients receive CMR.

OTHER

fasting

At the beginning of the study, the patients need to fast when receive UCG.

Sponsors & Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Maohuan Lin, PhD · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06266858 on ClinicalTrials.gov